XML 29 R4.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Operations and Comprehensive (Loss) Income - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Revenue:      
Total revenue $ 371,206 $ 1,198 $ 914,963
Operating expenses:      
Research and development 387,332 461,645 340,567
General and administrative 76,162 102,464 99,690
Collaboration expense, net 130,250 110,250 101,178
Total operating expenses 593,744 674,359 541,435
(Loss) income from operations (222,538) (673,161) 373,528
Other income      
Other income, net 71,816 22,661 6,003
Total other income, net 71,816 22,661 6,003
Net income (loss) before income taxes (150,722) (650,500) 379,531
(Provision) benefit for income taxes (2,888) 325 (1,870)
Net (loss) income (153,610) (650,175) 377,661
Foreign currency translation adjustment 73 (80) (11)
Unrealized gain (loss) on marketable securities 17,487 (10,500) (4,973)
Comprehensive (loss) income $ (136,050) $ (660,755) $ 372,677
Net (loss) income per common share - basic $ (1.94) $ (8.36) $ 4.97
Basic weighted-average common shares outstanding 79,220,930 77,746,575 75,948,686
Net (loss) income per common share - diluted $ (1.94) $ (8.36) $ 4.7
Diluted weighted-average common shares outstanding 79,220,930 77,746,575 80,393,496
Collaboration Revenue [Member]      
Revenue:      
Total revenue $ 370,000 $ 436 $ 913,081
Grant Revenue [Member]      
Revenue:      
Total revenue $ 1,206 $ 762 $ 1,882